| Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial. | |
| | |
MedLine Citation:
|
PMID: 15923689 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To test the hypothesis that daily supplementation of zinc and copper mixed with the oral rehydration solution (ORS) reduces the duration and the severity of acute diarrhea in children. METHODS: In a randomized, double blind, placebo controlled trial children aged 6 months to 59 months in an urban hospital with acute diarrhea, were assigned to receive the intervention of once daily 40 mg of zinc sulfate and 5 mg of copper sulfate dissolved in a liter of standard ORS (n = 102) or placebo (50 mg of standard ORS powder) dissolved in a liter of ORS (n = 98). RESULT: The baseline characteristics in the two groups were similar. The mean survival time (days) (SE) with diarrhea was not significantly different in the treatment (4.34 (0.2)) as compared to the placebo group (4.48 (0.2)), nor was there any difference in the median time to cure. Cure was less likely with longer duration of diarrhea prior to enrollment (P < 0.001), if the time taken for rehydration was more (P = 0.001) and if intravenous fluids were used (P = 0.03) regardless of the micronutrient supplementation. The proportion of children with diarrhea > 4 days was 46% in the placebo group with an adjusted odds ratio (OR) (95% CI) of 1.19 (1.58, 0.9; P = 0.2) as compared to 39% in the supplemented group. The most important risk factor for diarrhea > 4 days was diarrheal duration prior to enrollment with OR = 6.25 (3.7, 11.1). The supplemented group however had less severity of diarrhea with a lower proportion of children requiring unscheduled intravenous fluids (OR = 0.4; 95% CI 0.05, 2.2), with weight loss (OR = 0.7; 95% CI; 0.4, 1.3), with complications (OR = 0.15; 0.01, 1.3) and had no deaths as compared to two in the placebo group. CONCLUSIONS: This study showed that the most important predictor for duration of diarrhea in children was the severity of the disease at enrollment, and, not the supplementation. There were clinical beneficial effects of supplementation on rate of any complications and mortality. A larger trial is warranted before supplementation of micronutrients mixed with ORS are recommended for management of acute diarrhea. |
| | |
Authors:
|
Archana B Patel; Leena A Dhande; Manwar S Rawat |
Related Documents
:
|
17256759 - A randomized controlled trial of licartin for preventing hepatoma recurrence after live... 23628529 - Controlling social desirability may attenuate faking effects:a study with aggression me... 22991249 - Is the sino-nasal outcome test-22 a suitable evaluation for septorhinoplasty? 23127379 - Characteristics of suicide attempts in patients diagnosed with schizophrenia in compari... 19642839 - Onset and disappearance rates of gastroesophageal reflux symptoms in the spanish popula... 14871419 - Willingness of dialysis patients to participate in a randomized controlled trial of dai... 1529149 - A double blind, placebo controlled trial of efficacy and safety of oral acyclovir (zovi... 12718739 - Etanercept in psoriatic arthritis. 6219129 - The use of the mmpi in a chronic back pain rehabilitation program. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Indian pediatrics Volume: 42 ISSN: 0019-6061 ISO Abbreviation: Indian Pediatr Publication Date: 2005 May |
Date Detail:
|
Created Date: 2005-05-30 Completed Date: 2006-09-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2985062R Medline TA: Indian Pediatr Country: India |
Other Details:
|
Languages: eng Pagination: 433-42 Citation Subset: IM |
Affiliation:
|
Clinical Epidemiology Unit, Indira Gandhi Medical College, Nagpur 440 018, Maharashtra, India. archana_patel@vsnl.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Analysis of Variance Child, Preschool Copper Sulfate / therapeutic use* Diarrhea / drug therapy* Double-Blind Method Drug Therapy, Combination Female Fluid Therapy / methods* Humans Infant Male Proportional Hazards Models Trace Elements / therapeutic use* Zinc Sulfate / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Trace Elements; 7733-02-0/Zinc Sulfate; 7758-98-7/Copper Sulfate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Community-based nutrition education for improving infant growth in rural Karnataka.
Next Document: Meropenem.